Diffusion-weighted MRI and its role in prostate cancer

NMR Biomed. 2014 Jan;27(1):25-38. doi: 10.1002/nbm.2956. Epub 2013 May 27.

Abstract

In the last 5 years, the multiparametric approach has been investigated as the method for the MRI of prostate cancer. In multiparametric MRI of the prostate, at least two functional MRI techniques, such as diffusion-weighted MRI (DW-MRI) and dynamic contrast-enhanced MRI, are combined with conventional MRI, such as T2 -weighted imaging. DW-MRI has the ability to qualitatively and quantitatively represent the diffusion of water molecules by the apparent diffusion coefficient, which indirectly reflects tissue cellularity. DW-MRI is characterized by a short acquisition time without the administration of contrast medium. Thus, DW-MRI has the potential to become established as a noninvasive diagnostic method for tumor detection and localization, tumor aggressiveness, local staging and local recurrence after various therapies. Accordingly, radiologists should recognize the principles of DW-MRI, the methods of image acquisition and the pitfalls of image interpretation.

Keywords: Gleason score; MRI; apparent diffusion coefficient; diffusion-weighted MRI; histologic type of neoplasm; peripheral zone; prostate cancer; transition zone.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Diffusion Magnetic Resonance Imaging*
  • Humans
  • Image Interpretation, Computer-Assisted
  • Male
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / therapy